Relmada Therapeutics, Inc.
RLMD • NASDAQ • Stock Fundamentals
Relmada Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sergio Traversa, with a market cap of $752.1M.
Market Cap$752.1M
Employees20.0
CEOSergio Traversa
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Relmada Therapeutics, Inc. FAQ
Common questions about Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) has a market capitalization of $752.1M and trades on NASDAQ.
Relmada Therapeutics, Inc. has approximately 20 employees.